Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JMJD6 | Q6NYC1 | 11/20 | 0.55 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | CCR8 | P51685 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16139810 | 0.89 | JMJD6 (0.51) | JMJD6PIK3CAMEN1NPC1RAB9A | |
| SCHEMBL12958351 | 0.88 | JMJD6 (0.53) | JMJD6PIK3CAMEN1NPC1RAB9A | |
| SCHEMBL13119710 | 0.88 | JMJD6 (0.66) | JMJD6PIK3CACCR1CCR5CCR8 | |
| SCHEMBL12893308 | 0.86 | JMJD6 (0.67) | JMJD6PIK3CACA12CA1CA2 | |
| SCHEMBL16139799 | 0.86 | JMJD6 (0.51) | JMJD6PIK3CAMEN1NPC1RAB9A | |
| SCHEMBL2688111 | 0.85 | JMJD6 (0.68) | JMJD6PIK3CAMEN1NPC1RAB9A | |
| SCHEMBL12958414 | 0.83 | JMJD6 (0.46) | JMJD6MEN1NPC1RAB9AKMT2A | |
| SCHEMBL12958319 | 0.82 | JMJD6 (0.45) | JMJD6MEN1NPC1RAB9AKMT2A | |
| SCHEMBL3442984 | 0.81 | JMJD6 (0.49) | JMJD6PIK3CA | |
| SCHEMBL6414485 | 0.81 | JMJD6 (0.49) | JMJD6PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580961-B2 | 2-phenyl-6-azolylpyridine-based ligand and group VIII transition metal complex | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-11-12 | — | — | US | disclosed |
| US-20130018189-A1 | 2-PHENYL-6-AZOLYLPYRIDINE-BASED LIGAND AND GROUP VIII TRANSITION METAL COMPLEX | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018189-A1 | 2-PHENYL-6-AZOLYLPYRIDINE-BASED LIGAND AND GROUP VIII TRANSITION METAL COMPLEX | C1S, H1-10, INTS6 | JMJD6 483/4885PIK3CA 2878/4885CCR1 224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.